Division of Cardiovascular Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Artif Organs. 2013 Jan;37(1):21-8. doi: 10.1111/aor.12032.
Technological development has had a tremendous impact on the management of patients who require extracorporeal membrane oxygenation (ECMO). Team development and education are a vital component of a successful extracorporeal life support (ECLS) Program to reduce complications and subsequently improve clinical outcomes. We sought to review the evolution in technology, importance of team development and training, and report our experience at The Hospital for Sick Children, Toronto. There were a total of 576 ECMO runs in 534 patients (42 repeat ECMO runs) between January 1988 and June 2012. The use of ECMO for cardiac disease has increased in the last decade due to an expanded indication for ECMO in patients with single-ventricle physiology. Cardiac ECMO still remains a challenge in terms of survival (177/392, 45%). Although development of an ECLS program and team education facilitated extracorporeal cardiopulmonary resuscitation, clinical outcomes were not satisfactory (survival, 33%). The most common complications were hemorrhagic (13.8%), followed by renal (10.6%) and pulmonary dysfunction (6.9%). Advances in technology made management during ECMO safer, and the mechanical complications related to the ECMO system were 6.1%, including circuit changes due to thrombus formation, cannula repositioning, or optimization of size.
技术的发展对需要体外膜肺氧合(ECMO)的患者的管理产生了巨大影响。团队的发展和教育是成功的体外生命支持(ECLS)计划的重要组成部分,可以减少并发症,从而改善临床结果。我们回顾了技术的发展、团队发展和培训的重要性,并报告了我们在多伦多 SickKids 医院的经验。在 1988 年 1 月至 2012 年 6 月期间,共有 534 例患者(42 例重复 ECMO 运行)进行了 576 次 ECMO 运行。由于单心室生理患者 ECMO 的适应证扩大,过去十年中 ECMO 在心脏病中的应用有所增加。心脏 ECMO 在生存率方面仍然是一个挑战(392 例中有 177 例,45%)。尽管 ECLS 计划和团队教育的发展促进了体外心肺复苏,但临床结果并不令人满意(存活率为 33%)。最常见的并发症是出血(13.8%),其次是肾功能障碍(10.6%)和肺部功能障碍(6.9%)。技术的进步使 ECMO 期间的管理更安全,与 ECMO 系统相关的机械并发症为 6.1%,包括由于血栓形成、插管重新定位或大小优化而导致的回路变化。